Brief interventions for alcohol misuse among people living with HIV: a meta-analysis.

IF 2.7 3区 医学 Q2 PSYCHOLOGY, CLINICAL
Abhishek Ghosh, Geetesh K Singh, Nidhi Yadav, Pranshu Singh, Sanjana Kathiravan
{"title":"Brief interventions for alcohol misuse among people living with HIV: a meta-analysis.","authors":"Abhishek Ghosh, Geetesh K Singh, Nidhi Yadav, Pranshu Singh, Sanjana Kathiravan","doi":"10.1080/00952990.2023.2248647","DOIUrl":null,"url":null,"abstract":"<p><p><i>Background:</i> One-third of people living with HIV (PLHIV) have alcohol misuse or alcohol use disorders which negatively affect course and outcome of HIV.<i>Objectives:</i> The meta-analysis sought to evaluate the effectiveness of brief interventions (BI) on alcohol and HIV outcomes in PLHIV with alcohol misuse.<i>Methods:</i> We included clinical trials published between 1990 and September 2022 on adults with harmful/hazardous alcohol use; only randomized clinical trials (RCTs) were included in the meta-analysis. We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Clinical Trials.Gov, and the World Health Organization's International Clinical Trials Registry Platform databases. Cochrane's risk-of-bias assessment was used.<i>Results:</i> Eighteen studies were included in the narrative synthesis, and a meta-analysis could be performed on 13 studies. Among the included RCTs, seven showed a low risk and two showed a high risk of bias; others showed some concerns. There was no evidence of publication bias. Compared to the control, BI significantly reduces the drinks per drinking day (<i>N</i> = 5, Hedge's g= -0.45, 95%CI = -0.58, -0.32) and the number of heavy drinking days (<i>N</i> = 4, Hedge'sg = -0.81, 95% CI= -0.94, -0.67) between 3-6 months post-intervention. BI also reduces the odds of mortality by 42% (<i>N</i> = 7, OR = 0.58, 95% CI = 0.34, 0.99) in 6-12 months. BI does not change the alcohol risk scores and transition to harmful alcohol use; it does not improve adherence to Anti-Retroviral Therapy and increase viral suppression.<i>Conclusion:</i> Policymakers must introduce and scale up integrated screening and brief intervention services within HIV clinics and primary care.</p>","PeriodicalId":48957,"journal":{"name":"American Journal of Drug and Alcohol Abuse","volume":" ","pages":"766-786"},"PeriodicalIF":2.7000,"publicationDate":"2023-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Drug and Alcohol Abuse","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00952990.2023.2248647","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/11 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: One-third of people living with HIV (PLHIV) have alcohol misuse or alcohol use disorders which negatively affect course and outcome of HIV.Objectives: The meta-analysis sought to evaluate the effectiveness of brief interventions (BI) on alcohol and HIV outcomes in PLHIV with alcohol misuse.Methods: We included clinical trials published between 1990 and September 2022 on adults with harmful/hazardous alcohol use; only randomized clinical trials (RCTs) were included in the meta-analysis. We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Clinical Trials.Gov, and the World Health Organization's International Clinical Trials Registry Platform databases. Cochrane's risk-of-bias assessment was used.Results: Eighteen studies were included in the narrative synthesis, and a meta-analysis could be performed on 13 studies. Among the included RCTs, seven showed a low risk and two showed a high risk of bias; others showed some concerns. There was no evidence of publication bias. Compared to the control, BI significantly reduces the drinks per drinking day (N = 5, Hedge's g= -0.45, 95%CI = -0.58, -0.32) and the number of heavy drinking days (N = 4, Hedge'sg = -0.81, 95% CI= -0.94, -0.67) between 3-6 months post-intervention. BI also reduces the odds of mortality by 42% (N = 7, OR = 0.58, 95% CI = 0.34, 0.99) in 6-12 months. BI does not change the alcohol risk scores and transition to harmful alcohol use; it does not improve adherence to Anti-Retroviral Therapy and increase viral suppression.Conclusion: Policymakers must introduce and scale up integrated screening and brief intervention services within HIV clinics and primary care.

艾滋病毒感染者滥用酒精的简短干预措施:一项荟萃分析。
背景:三分之一的HIV感染者(PLHIV)存在酒精滥用或酒精使用障碍,这对HIV的病程和结果产生了负面影响。目的:荟萃分析旨在评估短暂干预(BI)对酒精滥用的PLHIV患者的酒精和HIV结果的有效性。方法:我们纳入了1990年至2022年9月期间发表的关于成年人有害/危险饮酒的临床试验;只有随机临床试验(RCT)被纳入荟萃分析。我们搜索了MEDLINE、EMBASE、Cochrane对照试验中央注册中心、临床试验.Gov和世界卫生组织的国际临床试验注册平台数据库。采用Cochrane的偏倚风险评估。结果:18项研究被纳入叙事综合,13项研究可以进行荟萃分析。在纳入的随机对照试验中,7项风险较低,2项风险较高;其他人则表示了一些担忧。没有证据表明存在出版偏见。与对照组相比,BI显著降低了每日饮酒量(N = 5,Hedge的g=-0.45,95%置信区间 = -0.58、-0.32)和大量饮酒天数(N = 4、套期保值 = -0.81,95%CI=-0.94,-0.67)在3-6之间 干预后数月。BI还可将死亡率降低42%(N = 7,或 = 0.58,95%CI = 0.34,0.99) 月。BI不会改变饮酒风险评分,也不会转变为有害饮酒;它不会提高对抗逆转录病毒治疗的依从性并增加病毒抑制。结论:政策制定者必须在艾滋病毒诊所和初级保健中引入并扩大综合筛查和短期干预服务。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.70
自引率
3.70%
发文量
68
期刊介绍: The American Journal of Drug and Alcohol Abuse (AJDAA) is an international journal published six times per year and provides an important and stimulating venue for the exchange of ideas between the researchers working in diverse areas, including public policy, epidemiology, neurobiology, and the treatment of addictive disorders. AJDAA includes a wide range of translational research, covering preclinical and clinical aspects of the field. AJDAA covers these topics with focused data presentations and authoritative reviews of timely developments in our field. Manuscripts exploring addictions other than substance use disorders are encouraged. Reviews and Perspectives of emerging fields are given priority consideration. Areas of particular interest include: public health policy; novel research methodologies; human and animal pharmacology; human translational studies, including neuroimaging; pharmacological and behavioral treatments; new modalities of care; molecular and family genetic studies; medicinal use of substances traditionally considered substances of abuse.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信